Join to View Full Profile
3181 SW Sam Jackson Park Road, 2nd Floor, Portland, ORPortland, OR 97239
Phone+1 503-494-5058
Dr. Traer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2006 - 2009
- University of Texas Southwestern Medical SchoolClass of 2006
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology
Certifications & Licensure
- OR State Medical License 2009 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2021 Jan 14
Roles: Principal Investigator, Contact
- A Study of TAS1440 With ATRA in Subjects With r/r AML Start of enrollment: 2020 Mar 15
Roles: Contact
- Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Roles: Contact
Publications & Presentations
PubMed
- Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.Fieke W Hoff, Ying Huang, Rina Li Welkie, Ronan T Swords, Elie Traer
Blood Cancer Journal. 2025-04-03 - 1 citationsThromboprophylaxis with intermediate dose enoxaparin during asparaginase containing induction for young adults with acute lymphoblastic leukemia.Hong De Sa, Thomas Deloughery, Andy Kaempf, Curtis Lachowiez, Jessica Leonard
Leukemia & Lymphoma. 2025-01-01 - 22 citationsMenin Inhibition With Revumenib for-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, John DiPersio, Martha Arellano
Journal of Clinical Oncology. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: